After 11 years in commercial operations and managed markets, I have a running spreadsheet. It isn't a complex CRM export or a fancy BI dashboard. It is a simple, brutal list titled "Who I Actually Met vs. Who I Was Promised." It tracks every conference, congress, and roundtable I’ve attended since 2013. When I look at that list, the distinction between "big conferences" and "closed-door executive forums" isn't just a matter of preference—it’s a matter of market access survival.
Most commercial teams are addicted to the pageantry of big events. We pay for the booth, we prep the talking heads, and we hope that "great networking" happens. But let’s be honest: standing in an exhibit hall at an AMCP or ACCC meeting is not where formulary access happens. It is where you go to get scanned by people who have no power to change a PA (Prior Authorization) requirement or initiate a P&T committee review.
If you want to move the needle on formulary access execution, you have to stop chasing volume and start chasing intent.
The Fallacy of "Big Conference" Success
When I hear someone say, "We had a great presence at the last congress," I immediately ask: How many access decisions were made in that hallway? The answer is almost always zero.
Big industry gatherings like AMCP or ACCC are fantastic for understanding the "vibe" of the market. They are where you see the trends in https://pharmashots.com/33979/pharma-market-access-conferences-2026/ digital evidence generation tools, and they are where you get a sense of what your competitors are saying. But they are essentially public theater. You are fighting for attention alongside three dozen other manufacturers, and the decision-makers you actually need to talk to are usually hiding in the back of a session or catching a flight home.
In contrast, a closed-door executive forum is a tactical engagement. At an organization like The Health Management Academy (THMA), the barrier to entry is high, and the audience is curated. You aren't pitching to a regional manager who is worried about their monthly sales target; you are talking to the individuals who own the health system decision-making process.
Comparing the Environments
Factor Big Conferences (AMCP/ACCC) Closed-Door Executive Forums Primary Goal Brand Awareness / Broad Reach Formulary Access Execution Audience Variable (Sales, Ops, Students, Reps) C-Suite / Payer Leadership Conversations Surface-level / transactional Strategic / HTA-focused ROI Hard to attribute Direct pipeline to decision makersWhy Closed-Door Forums Win on Payer Strategy
Payer expectations have evolved. They no longer care about your glossy brochure. They care about affordability, HTA (Health Technology Assessment) pressure, and whether your product is going to break their pharmacy budget next quarter. You cannot explain complex reimbursement models in a noisy exhibit hall while a generic "Cookie Law Info" plugin UI element is popping up on your tablet because the Wi-Fi is failing.
In a closed-door environment, the conversation shifts from "What are your features?" to "How do we integrate this into our clinical pathway without blowing up our formulary?" This is the core of effective health system decision-making. When you are sitting in a boardroom with five health system executives, you aren't just presenting data; you are stress-testing your commercial strategy against their real-world budget constraints.
You don't need a massive booth at a forum. You need a clean, defensible evidence generation strategy and the ability to answer the question: "Why should I choose this over the competitor I already have in my formulary?"
The "Monday Morning" Audit
My favorite thing to do after a conference is to sit down on the first Monday back and ask: "What would I do differently on Monday?"
If the answer is "nothing" because the people I met are not in a position to influence local coverage policy, then the conference was a waste of the budget. If I attended an executive forum, my Monday morning usually looks like this:
Follow-up on specific evidence gaps identified by a system leader. Refining the value proposition for a specific formulary committee based on the feedback from the roundtable. Updating our internal P&T briefing materials to reflect the HTA pressure mentioned by the payer lead.Notice that "networking" isn't on the list. Networking is what happens when you don't have a plan. Strategic engagement is what happens when you know exactly who you need to talk to and what problem you are solving for them.
Stop Hiding Behind Buzzwords
I am tired of hearing marketing teams talk about "synergy" and "streamlining the customer journey." These are words people use when they aren't actually doing the work of market access. Formulary access execution is unglamorous. It is granular. It is about understanding the specific reimbursement roadblocks in a hospital system and building a digital tool that helps the pharmacy team clear those hurdles efficiently.
When you are at a large conference, these details get lost in the noise. At an executive forum, they are the only things on the table. If you can’t defend your pricing strategy to an executive who is staring at a declining bottom line, you haven't done your homework. A fancy presentation won't save you there.
Final Thoughts: Invest in Depth, Not Width
If you are responsible for market access strategy, you need to be surgical. The industry has reached a point where broad-spectrum marketing to payers is largely ineffective. They are under too much HTA pressure to listen to general value pitches.
Here is my challenge to you for the next quarter:
- Take 20% of your budget from the "large expo" line item. Allocate that to a targeted, invite-only roundtable or forum. Track the names of the five people you need to influence. Measure your success by the specific feedback you receive on your formulary strategy, not the number of badges you scanned.
Stop playing the game of numbers. Start playing the game of access. If you can’t identify exactly how a conversation is going to change a formulary decision, skip the conference and stay in the office to do the real work. That is how you actually win.